IP Library › Granted Patent US 11,583,678
Granted Patent B2
US 11,583,678 · App. 16/942,314 · Granted Feb 21, 2023

Neurostimulation system with neurodegenerative disease detection

Inventors: Rosana Esteller (Santa Clarita, CA); Joseph M. Bocek (Seattle, WA); Sridhar Kothandaraman (Valencia, CA)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36082A61B5/24A61N1/0456A61N1/0551A61N1/36031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,583,678
App. No.
16/942,314
Granted
Feb 21, 2023
Kind
B2
Abstract

An example of a system for delivering neurostimulation energy to a patient using a plurality of electrodes may include a stimulation circuit and a sensing circuit. The stimulation circuit may be configured to deliver the neurostimulation energy using stimulation electrodes selected from the plurality of electrodes and to control the delivery of the neurostimulation energy. The sensing circuit may be configured to receive one or more neural signals from sensing electrodes selected from the plurality of electrodes and may include a signal processing circuit. The signal processing circuit may include a detection circuit and an analysis circuit. The detection circuit may be configured to detect one or more attributes of neural responses from the received one or more neural signals. The analysis circuit may be configured to analyze the detected one or more attributes of the neural responses for one or more indications of a neurodegenerative disease.

Claims (34)

1. A system for delivering neurostimulation energy to a patient using a plurality of electrodes, the system comprising:

a stimulation circuit configured to deliver neurostimulation pulses using stimulation electrodes selected from the plurality of electrodes and to control the delivery of the neurostimulation pulses; and

a sensing circuit configured to receive one or more neural signals from sensing electrodes selected from the plurality of electrodes and including a signal processing circuit including:

a detection circuit configured to detect one or more attributes of evoked responses from the received one or more neural signals, the evoked responses each being a neural response evoked by a pulse of the neurostimulation pulses; and

an analysis circuit configured to analyze the detected one or more attributes of the evoked responses for one or more indications of a neurodegenerative disease.

2. The system of claim 1 , further comprising a memory circuit configured to store the detected one or more attributes of the evoked responses, and wherein the analysis circuit is further configured to analyze the detected one or more attributes of the evoked responses over time for a level of disease progression in the neurodegenerative disease.

3. The system of claim 2 , wherein the analysis circuit is further configured to generate at least one of a disease alert or a disease progression alert, the disease alert to be generated in response to the neurodegenerative disease being indicated as an outcome of the analysis, the disease progression alert to be generated in response to the level of disease progression being above a threshold level.

4. The system of claim 1 , wherein the stimulation circuit is configured to deliver spinal cord stimulation, the sensing circuit is configured to sense one or more electrospinogram signals, and the detection circuit is configured to detect a morphology of the evoked responses.

5. The system of claim 1 , comprising an implantable stimulator including the stimulation circuit and the sensing circuit.

6. The system of claim 5 , further comprising a transcutaneous electrical nerve stimulation (TENS) device including surface stimulation electrodes configured to be attached onto the patient, wherein the TENS device is configured to deliver external stimulation pulses using the surface stimulation electrodes, and the detection circuit is further configured to detect neural responses each evoked by a pulse of the external stimulation pulses.

7. The system of claim 1 , wherein the detection circuit is configured to detect a neural conduction velocity (NCV) of the evoked responses.

8. The system of claim 7 , wherein the detection circuit is configured to detect the NCV by detecting at least one of a time interval during which a detected feature of the evoked responses travels a known distance or a time interval between a response of the detected evoked responses and the pulse evoking that response, and the analysis circuit is configured to compare the detected NCV to an NCV threshold range for an NCV-based indication of the one or more indications of one or more neurodegenerative diseases.

9. The system of claim 1 , wherein the detection circuit is configured to detect a morphology of the evoked responses, the morphology to be detected including an evoked response waveform or one or more morphological parameters representing the evoked response waveform.

10. The system of claim 9 , wherein the analysis circuit is configured to compare the detected morphology to a stored template morphology for a morphology-based indication of the one or more indications of one or more neurodegenerative diseases.

11. A method for operating a system configured for delivering neurostimulation energy to a patient using a plurality of electrodes, the method comprising:

delivering neurostimulation pulses using stimulation electrodes selected from the plurality of electrodes;

controlling the delivery of the neurostimulation pulses;

receiving one or more neural signals from sensing electrodes selected from the plurality of electrodes;

detecting one or more attributes of evoked responses from the one or more neural signals, the evoked responses each being a neural response evoked by a pulse of the neurostimulation pulses; and

analyzing the detected one or more attributes of the evoked responses for one or more indications of a neurodegenerative disease.

12. The method of claim 11 , further comprising performing the method for a preventive check of health of the patient's nervous system.

13. The method of claim 11 , further comprising performing the method repeatedly over time to track progression of the neurodegenerative disease.

14. The method of claim 11 , wherein delivering the neurostimulation energy comprises delivering the neurostimulation pulses from an implantable stimulator coupled to the stimulation electrodes selected from the plurality of electrodes.

15. The method of claim 11 , wherein delivering the neurostimulation energy comprises delivering the neurostimulation pulses from at least one of an implantable stimulator coupled to the stimulation electrodes selected from the plurality of electrodes or a transcutaneous electrical nerve stimulation (TENS) device including surface stimulation electrodes configured to be attached onto the patient.

16. The method of claim 11 , wherein detecting the one or more attributes of the evoked responses comprises detecting a neural conduction velocity (NCV).

17. The method of claim 16 , wherein detecting the NCV comprises detecting at least one of a time interval during which a detected feature of the evoked responses travels a known distance or a time interval between a response of the detected evoked responses and the pulse evoking that response, and analyzing the detected one or more attributes of the evoked responses comprises comparing the detected NCV to an NCV threshold range for an NCV-based indication of the one or more indications of one or more neurodegenerative diseases.

18. The method of claim 11 , wherein detecting the one or more attributes of the neural evoked responses comprises detecting a morphology of the evoked responses, the morphology to be detected including an evoked response waveform or one or more morphological parameters representing the evoked response waveform.

19. The method of claim 18 , wherein analyzing the detected one or more attributes of the evoked responses comprises comparing the detected morphology to a stored template morphology for a morphology-based indication of the one or more indications of one or more neurodegenerative diseases.

20. A non-transitory computer-readable storage medium including instructions, which when executed by a machine, cause the machine to perform a method for operating a system configured for delivering neurostimulation energy to a patient using a plurality of electrodes, the method comprising:

delivering neurostimulation pulses using stimulation electrodes selected from the plurality of electrodes;

controlling the delivery of the neurostimulation pulses;

receiving one or more neural signals from sensing electrodes selected from the plurality of electrodes;

detecting one or more attributes of evoked responses from the one or more neural signals, the evoked responses each being a neural response evoked by a pulse of the neurostimulation pulses; and

analyzing the detected one or more attributes of the evoked responses for one or more indications of a neurodegenerative disease.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2023
From: KOTHANDARAMAN, SRIDHAR
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 064754/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2020
From: ESTELLER, ROSANA; BOCEK, JOSEPH M.
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 053345/0959 →
Continuity (2)
Provisional Application 62882272 · Aug 2, 2019
Related Publication 20210031043A1 · Feb 4, 2021
Cited By (3)
US 12,285,613 US 12,714,859 US 12,734,362